Summary

TrovaGene, Inc. (TrovaGene), formally Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company has worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in California, the US.

TrovaGene operates with the strategic intent of developing and marketing molecular diagnostic products in the areas of markets cancer treatment, infectious disease, transplantation, and prenatal diagnostics based on transrenal cell-free nucleic acid technology. In line with this objective the company establishes and nourishes collaborations with several research institutes and companies. Recently the company entered into collaborations with Dana-Farber Cancer Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute for the advancement of its candidates.

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
TrovaGene, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
TrovaGene, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
Venture Financing 12
TrovaGene Raises US$6.6 Million In Venture Financing 12
Partnerships 13
Trovagene Enters Into Licensing Agreement with GenSignia IP 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
TrovaGene Enters Into An Agreement With Skyline Diagnostics 16
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 17
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 18
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 20
Equity Offering 21
Trovagene Completes Public Offering of Shares for USD23 Million 21
Trovagene Completes Private Placement Of Shares For US$15 Million 23
Trovagene Completes Private Placement Of Units For US$4 Million 25
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 26
TrovaGene, Inc. - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations and Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables

TrovaGene, Inc., Medical Equipment, Key Facts, 2013 1
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
TrovaGene, Inc., Deals By Market, 2009 to YTD 2015 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
TrovaGene Raises US$6.6 Million In Venture Financing 12
Trovagene Enters Into Licensing Agreement with GenSignia IP 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
TrovaGene Enters Into An Agreement With Skyline Diagnostics 16
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 17
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 18
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 20
Trovagene Completes Public Offering of Shares for USD23 Million 21
Trovagene Completes Private Placement Of Shares For US$15 Million 23
Trovagene Completes Private Placement Of Units For US$4 Million 25
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 26
TrovaGene, Inc., Key Competitors 28
TrovaGene, Inc., Key Employees 29
TrovaGene, Inc., Other Locations 30

List of Figures

TrovaGene, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
TrovaGene, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
TrovaGene, Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

  • $ 23 500
  • Industry report
  • May 2015
  • by Venture Planning Group

"2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market" is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

2015 Strategies in the Global Microbiology Market

2015 Strategies in the Global Microbiology Market

  • $ 21 100
  • Industry report
  • May 2015
  • by Venture Planning Group

2015 Strategies in the Global Microbiology Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  ...

2015 Strategies in the Global Hemostasis Diagnostic Testing Market

2015 Strategies in the Global Hemostasis Diagnostic Testing Market

  • $ 21 100
  • Industry report
  • May 2015
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.